Sui‐Po Zhang

1.2k total citations
45 papers, 976 citations indexed

About

Sui‐Po Zhang is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Sensory Systems. According to data from OpenAlex, Sui‐Po Zhang has authored 45 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 27 papers in Cellular and Molecular Neuroscience and 7 papers in Sensory Systems. Recurrent topics in Sui‐Po Zhang's work include Receptor Mechanisms and Signaling (16 papers), Pharmacological Receptor Mechanisms and Effects (12 papers) and Neuropeptides and Animal Physiology (10 papers). Sui‐Po Zhang is often cited by papers focused on Receptor Mechanisms and Signaling (16 papers), Pharmacological Receptor Mechanisms and Effects (12 papers) and Neuropeptides and Animal Physiology (10 papers). Sui‐Po Zhang collaborates with scholars based in United States. Sui‐Po Zhang's co-authors include Benjamin Weiss, Long-Wu Zhou, Ellen E. Codd, Christopher M. Flores, Scott L. Dax, Zhen Qin, Genoveva Davidkova, Zheng‐Hong Qin, Na Qin and Dennis J. Stone and has published in prestigious journals such as Biological Psychiatry, Journal of Medicinal Chemistry and Journal of Lipid Research.

In The Last Decade

Sui‐Po Zhang

44 papers receiving 952 citations

Peers

Sui‐Po Zhang
Carol S. Surowy United States
Laura Rauser United States
Kathy Sutton United Kingdom
Amy Gustafson United States
Tino Dyhring Denmark
Sang June Hahn South Korea
Sui‐Po Zhang
Citations per year, relative to Sui‐Po Zhang Sui‐Po Zhang (= 1×) peers Bernard Bucher

Countries citing papers authored by Sui‐Po Zhang

Since Specialization
Citations

This map shows the geographic impact of Sui‐Po Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sui‐Po Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sui‐Po Zhang more than expected).

Fields of papers citing papers by Sui‐Po Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sui‐Po Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sui‐Po Zhang. The network helps show where Sui‐Po Zhang may publish in the future.

Co-authorship network of co-authors of Sui‐Po Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Sui‐Po Zhang. A scholar is included among the top collaborators of Sui‐Po Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sui‐Po Zhang. Sui‐Po Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Bin, Peter J. Connolly, Sui‐Po Zhang, et al.. (2020). The discovery of diazetidinyl diamides as potent and reversible inhibitors of monoacylglycerol lipase (MAGL). Bioorganic & Medicinal Chemistry Letters. 30(12). 127198–127198. 7 indexed citations
2.
Douglass, John D., Yin Zhou, Angela M. Gajda, et al.. (2015). Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity. Journal of Lipid Research. 56(6). 1153–1171. 51 indexed citations
3.
Codd, Ellen E., et al.. (2011). Dynamic Mass Redistribution as a Means to Measure and Differentiate Signaling via Opioid and Cannabinoid Receptors. Assay and Drug Development Technologies. 9(4). 362–372. 21 indexed citations
4.
McNally, James J., Mark A. Youngman, Mark E. McDonnell, et al.. (2008). N-Pyridin-3-yl- and N-quinolin-3-yl-benzamides: Modulators of Human Vanilloid Receptor 1 (TRPV1). Bioorganic & Medicinal Chemistry Letters. 18(8). 2730–2734. 4 indexed citations
5.
Codd, E E, John R. Carson, Raymond W. Colburn, et al.. (2006). The Novel, Orally Active, Delta Opioid RWJ-394674 Is Biotransformed to the Potent Mu Opioid RWJ-413216. Journal of Pharmacology and Experimental Therapeutics. 318(3). 1273–1279. 14 indexed citations
6.
Qin, Na, et al.. (2005). Cloning, Expression, and Functional Characterization of Human Cyclooxygenase-1 Splicing Variants: Evidence for Intron 1 Retention. Journal of Pharmacology and Experimental Therapeutics. 315(3). 1298–1305. 60 indexed citations
7.
Carson, John R., Steven J. Coats, Ellen E. Codd, et al.. (2004). N , N -Dialkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, potent, selective δ opioid agonists. Bioorganic & Medicinal Chemistry Letters. 14(9). 2109–2112. 18 indexed citations
8.
Coats, Steven J., Mark J. Schulz, John R. Carson, et al.. (2004). Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonists. Bioorganic & Medicinal Chemistry Letters. 14(22). 5493–5498. 20 indexed citations
9.
Youngman, Mark A., James J. McNally, Sui‐Po Zhang, et al.. (2004). N-Isoquinolin-5-yl-N′-aralkyl-urea and -amide antagonists of human vanilloid receptor 1. Bioorganic & Medicinal Chemistry Letters. 14(12). 3053–3056. 18 indexed citations
10.
Youngman, Mark A., John R. Carson, Scott L. Dax, et al.. (2003). Synthesis and structure–Activity relationships of aroylpyrrole alkylamide bradykinin (B2) antagonists. Bioorganic & Medicinal Chemistry Letters. 13(7). 1341–1344. 4 indexed citations
11.
Baxter, Ellen W., et al.. (2001). Piperazinyl benzamidines: Synthesis and affinity for the delta opioid receptor. Bioorganic & Medicinal Chemistry Letters. 11(13). 1741–1743. 1 indexed citations
12.
Hou, Wangfang, Sui‐Po Zhang, Genoveva Davidkova, Robert A. Nichols, & Benjamin Weiss. (1998). Effect of Antisense Oligodeoxynucleotides Directed to Individual Calmodulin Gene Transcripts on the Proliferation and Differentiation of PC 12 Cells. Antisense and Nucleic Acid Drug Development. 8(4). 295–308. 9 indexed citations
13.
Weiss, Benjamin, Genoveva Davidkova, & Sui‐Po Zhang. (1997). Antisense strategies in neurobiology. Neurochemistry International. 31(3). 321–348. 50 indexed citations
14.
Weiss, Benjamin, et al.. (1997). Expression of a D2 dopamine receptor antisense RNA in brain inhibits D2-mediated behaviors. Neurochemistry International. 31(4). 571–580. 7 indexed citations
15.
Weiss, Benjamin, Sui‐Po Zhang, & Long-Wu Zhou. (1997). Antisense strategies in dopamine receptor pharmacology. Life Sciences. 60(7). 433–455. 23 indexed citations
17.
Qin, Zheng‐Hong, Long-Wu Zhou, Sui‐Po Zhang, Yumei Wang, & Benjamin Weiss. (1995). D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors.. Molecular Pharmacology. 48(4). 730–737. 30 indexed citations
18.
Zhang, Sui‐Po, et al.. (1995). Immunocytochemical localization of calmodulin in PC12 cells and its possible interaction with histones. Neurochemistry International. 26(5). 465–476. 8 indexed citations
20.
Zhang, Sui‐Po, Walter C. Prozialeck, & Benjamin Weiss. (1990). Differential inhibition of calcium-dependent and calmodulin-dependent enzymes by drug-calmodulin adducts.. Molecular Pharmacology. 38(5). 698–704. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026